Home » Newsletters » BioWorld

BioWorld

Jan. 21, 1993

View Archived Issues

IMAGING AGENT DETECTS LESIONS

ISIS COMPLETES OFFERING

CHEMEX COMPLETES ADDITIONAL TRIALS

FDA APPROVES ONCOR ASSAY

APPOINTMENTS AND ADVANCEMENTS

ESCAGENETICS COLLABORATES WITH GENENCOR

IMMUNE RESPONSE FILES IND

GTI TO CO-DEVELOP CANCER THERAPIES

LILLY TO WRITE OFF CENTOCOR EXPENSES

RECOMBINANT ANTI-TUMOR TOXIN

VESTAR SUES LTI OVER LIPOSOME PATENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.